7Baggers
 Actinium: Q3 Earnings Snapshot  San Francisco Chronicle Fri, 14 Nov 2025 22:09:53 GMT
 biotech stock faces critical test amid steep decline  AD HOC NEWS Fri, 07 Nov 2025 08:20:04 GMT
 published on: 2025-10-31 04:06:04  newser.com Fri, 31 Oct 2025 09:06:04 GMT

Actinium Pharmaceuticals, Inc
(NYSE MKT:ATNM) 

ATNM stock logo

Actinium Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a ...

Sector: Healthcare
Industry: Biotechnology

Share this website to your friends